FuNext Mycoprotein-Jiangxi Fushine Biotechnology Co., Ltd.
Fushine Secures National Invention Patent for Fusarium venenatum Mycoprotein Technology
Release time: 2024 / 10
Share:   


Invention Patent Introduction

Application of Fusarium venenatum in Mycoprotein Production

Fushine has recently been granted a national invention patent titled “Application of Fusarium venenatum in Mycoprotein Production” by the China National Intellectual Property Administration. This achievement marks an important milestone in Fushine’s progress in synthetic biology and brings new momentum to sustainable innovation in the food industry.

According to the 2022 article “Low-Carbon Biomanufacturing of Future Foods” published in the Journal of Biotechnology (38[11]: 4311–4328), Fusarium venenatum is a filamentous fungus widely used for fermenting and producing microbial protein. Compared with single-cell proteins such as yeast and bacteria, mycoprotein from filamentous fungi offers a more appealing flavor and naturally meat-like fiber structure. Its high dietary-fiber content also supports healthy digestion, making it a strong candidate for next-generation protein ingredients that meet modern nutritional needs.




Patent Prospects

National Policy Momentum: Advancing the “Great Food Perspective” and Building a Diversified Protein Future

In recent years, China’s “Great Food Perspective” has repeatedly appeared in national policy, quietly reshaping the future of the dining table. Driven by technological innovation, the boundaries of food are rapidly expanding—not limited to traditional grains, fruits, and vegetables, but now embracing microbial fermentation, synthetic biology, and next-generation food resources. This new paradigm encourages developing food from multiple channels to ensure security, diversity, and sustainability.

Building on its long-standing strengths in pharmaceutical biotechnology, Fushine has expanded into synthetic biology and microbial protein, becoming the first company in China to industrialize filamentous fungal protein at ton scale. The company has independently developed a new production strain of Fusarium venenatum with full intellectual property rights.

The project “Key Technologies and Industrial Application of Fusarium venenatum Fermentation for Microbial Protein Production” has been evaluated by the China Light Industry Federation as achieving an internationally advanced level, with its strain-selection technology rated as internationally leading. Experts unanimously recommended accelerating its adoption and wider application.

Supported by strong national policies and through persistent R&D effort, Fushine has now secured the invention patent for “Application of Fusarium venenatum in Mycoprotein Production.” This achievement not only reflects the company’s deep competence in biotechnology but also strengthens its industry leadership, enhances its intellectual property advantages, and positions Fushine favorably in the global competition for next-generation proteins.

Today, Fushine is steadily converting scientific achievements into real industrial productivity, bringing microbial protein products closer to everyday consumers. The company is also working closely with partners across the supply chain, increasing investment in research, and exploring new technologies and applications for microbial protein.

Looking ahead, the microbial protein industry is poised for rapid growth—driving a global shift toward green, healthy, and highly efficient food solutions, and opening a new chapter in sustainable nutrition.


Copyright ©  Jiangxi Fushine Biotechnology Co., Ltd. All rights reserved Web design